Clinical Trial Update: FOsfomycin for Male Urinary Tract Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating FOsfomycin for male urinary tract infection and prostatitis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis
• Prostatitis
• Urinary Tract Infection

Drugs mentioned

• Fosfomycin (Fosfomycin)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Urinary Tract Infection, Prostatitis | Phase 3 | Status: NOT_YET_RECRUITING